<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">russjcardiol</journal-id><journal-title-group><journal-title xml:lang="ru">Российский кардиологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Cardiology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-4071</issn><issn pub-type="epub">2618-7620</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">russjcardiol-1295</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>ПРЕДИКТОРНАЯ РОЛЬ ПОЛИМОРФИЗМОВ ХРОМОСОМЫ 9Sр21.3 И ИХ ВЗАИМОСВЯЗЬ С ОТЯГОЩЕННОЙ НАСЛЕДСТВЕННОСТЬЮ В РАЗВИТИИ ИНФАРКТА МИОКАРДА</article-title><trans-title-group xml:lang="en"><trans-title>PREDICTIVE ROLE OF CHROMOSOME 9P21.3 POLYMORPHISMS AND THEIR ASSOCIATION WITH FAMILY HISTORY OF CORONARY HEART DISEASE IN PATIENTS WITH MYOCARDIAL INFARCTION</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шестерня</surname><given-names>П. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shesternya</surname><given-names>P. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доцент кафедры внутренних болезней № 1</p></bio><email xlink:type="simple">shesternya75@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шульман</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shulman</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д. м.н., профессор кафедры внутренних болезней № 1</p></bio><email xlink:type="simple">shesternya75@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никулина</surname><given-names>С. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikulina</surname><given-names>S. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д. м.н., профессор, заведующая кафедрой внутренних болезней № 1</p></bio><email xlink:type="simple">shesternya75@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мартынова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Martynova</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант кафедры внутренних болезней № 1</p></bio><email xlink:type="simple">shesternya75@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Демкина</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Demkina</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант кафедры внутренних болезней № 1</p></bio><email xlink:type="simple">shesternya75@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Орлов</surname><given-names>П. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Orlov</surname><given-names>P. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>м. н.с., межинститутский сектор молекулярной эпидемиологии и эволюции человека</p></bio><email xlink:type="simple">shesternya75@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Максимов</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Maksimov</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д. м.н., зав. лабораторией молекулярно-генетических исследований терапевтических заболеваний</p></bio><email xlink:type="simple">shesternya75@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воевода</surname><given-names>М. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Voevoda</surname><given-names>M. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д. м.н., профессор, член-корреспондент РАМН, директор</p></bio><email xlink:type="simple">shesternya75@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБОУ ВПО Красноярский государственный медицинский университет имени проф. В. Ф. Войно-Ясенецкого Минздравсоцразвития РФ, Красноярск</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Prof. V. F. Voyno-Yasenetskyi Krasnoyarsk State Medical University, Krasnoyarsk</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ НИИ терапии СО РАМН, Новосибирск</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute of Internal Medicine, Siberian Branch, Russian Academy of Medical Sciences, Novosibirsk</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>28</day><month>12</month><year>2012</year></pub-date><volume>0</volume><issue>6</issue><fpage>14</fpage><lpage>18</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шестерня П.А., Шульман В.А., Никулина С.Ю., Мартынова Е.А., Демкина А.И., Орлов П.С., Максимов В.Н., Воевода М.И., 2012</copyright-statement><copyright-year>2012</copyright-year><copyright-holder xml:lang="ru">Шестерня П.А., Шульман В.А., Никулина С.Ю., Мартынова Е.А., Демкина А.И., Орлов П.С., Максимов В.Н., Воевода М.И.</copyright-holder><copyright-holder xml:lang="en">Shesternya P.A., Shulman V.A., Nikulina S.Y., Martynova E.A., Demkina A.I., Orlov P.S., Maksimov V.N., Voevoda M.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://russjcardiol.elpub.ru/jour/article/view/1295">https://russjcardiol.elpub.ru/jour/article/view/1295</self-uri><abstract><sec><title>Цель</title><p>Цель. Изучить взаимосвязь однонуклеотидных полиморфизмов (ОНП) rs10757278 и rs1333049 локуса 9Sр21.3 с наличием отягощенного семейного анамнеза у больных инфарктом миокарда (ИМ).  Материал и методы. Группа больных ИМ (n=243) и группа контроля (n=280) статистически не различались по полу, возрасту, артериальной гипертонии, сахарному диабету, гиперхолестеринемии, избыточной массе тела и ожирению, абдоминальному типу ожирения и анамнезу курения. Статистически значимые различия между группами имелись по отягощенной наследственности ИБС (р=0,004). Геномную ДНК выделяли из венозной крови методом фенол-хлороформной экстракции. ОНП rs10757278 (9p21.3) и rs1333049 (9Sр21.3) тестировали посредством ПЦР в режиме реального времени в соответствии с протоколом фирмы производителя (зонды TaqMan, Applied Biosystems, USA) на приборе AB 7900HT. Результаты. Выявлена статистически значимая ассоциация генотипов СС rs1333049 и GG rs10757278 с ИМ как в общей группе, так и при раз-дельном гендерном анализе. Отношение шансов развития ИМ у носителей генотипа СС rs1333049 в общей группе ИМ (ОШ=2,02; 95% ДИ=1,32– 3,08), у мужчин (ОШ=1,81; 95% ДИ=1,11–2,95), у женщин (ОШ=2,91; 95% ДИ=1,22–6,91); генотипа GG rs10757278 в общей группе ИМ (ОШ=1,98; 95% ДИ=1,30–3,02), у мужчин (ОШ=1,77; 95% ДИ=1,08–2,87), у женщин (ОШ=2,94; 95% ДИ=1,26–6,87). В подгруппе без семейного анамнеза ИБС риск развития ИМ у носителей генотипа СС rs1333049 (ОШ=1,92; 95% ДИ=1,16–3,16) и генотипа GG rs10757278 (ОШ=1,82; 95% ДИ=1,10–3,00) был сопоставим с таковым в подгруппе без отягощенной наследственности: у носителей генотипа СС rs1333049 (ОШ=2,19; 95% ДИ=1,28–3,75) и генотипа GG rs10757278 (ОШ=2,23; 95% ДИ=1,31–3,81). Заключение. Впервые в России проведен анализ взаимосвязи полиморфизмов локуса 9Sр21.3 хромосомы, ассоциированных с развитием ИМ, и отягощенной наследственности. Два ОНП rs1333049 и rs10757278 локуса 9p21.3 генома человека являются предикторами ИМ, независящими как от «традиционных» факторов риска, так и от наличия отягощенного семейного анамнеза.</p></sec><sec><title> </title><p> </p></sec></abstract><trans-abstract xml:lang="en"><p> Aim. To investigate the association between single-nucleotide polymorphisms (SNPs) rs10757278 and rs1333049 of the 9p21.3 locus and family history of coronary heart disease (CHD) in myocardial infarction (MI) patients. Material and methods. The MI group (n=243) and the control group (n=280) were comparable by such parameters as age, gender, arterial hypertension, diabetes mellitus, hypercholesterolemia, overweight and obesity, abdominal obesity, and smoking history. However, the groups were significantly different in terms of family history of CHD (p=0,004). Genome DNA was extracted from venous blood using the phenol-chloroform extraction method. The SNPs rs10757278 (9p21.3) and rs1333049 (9Sр21.3) were tested using real-time polymerase chain reaction (PCR) and the AB 7900HT device, according to the producer’s protocol (TaqMan probes, Applied Biosystems, USA). Results. A statistically significant association between MI and the CC rs1333049 genotype or the GG rs10757278 genotype was observed in the whole study sample and separately in men and women. The MI odds ratio (OR) for carriers of the CC rs1333049 genotype was 2,02 (95% confidence interval, CI, 1,32–3,08) in the whole sample, 1,91 (1,11–2,95) in men, and 2,91 (1,22–6,91) in women. For carriers of the GG rs10757278 genotype, respective OR values were 1,98 (1,30– 3,02), 1,77 (1,08–2,87), and 2,94 (1,26–6,87). Among participants without CHD in family history, OR for the CC rs1333049 genotype (1,92, 95% CI 1,16–3,16) and the GG rs10757278 genotype (1,82, 95% CI 1,10–3,00) were comparable for those among MI patients with CHD in family history (respective OR 2,19 (1,28–3,75) and 2,23 (1,31–3,81)). Conclusion. For the first time in Russia, the association between MI-related polymorphisms of the 9p21.3 chromosome and family history of CHD was analysed. Two SNPs (rs1333049 and rs10757278) of the 9p21.3 locus predicted MI risk independently from either conventional risk factors or CHD in family history. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>инфаркт миокарда</kwd><kwd>полиморфизмы</kwd><kwd>rs10757278</kwd><kwd>rs1333049</kwd><kwd>локус 9Sр21.3</kwd><kwd>наследственность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>myocardial infarction</kwd><kwd>polymorphisms</kwd><kwd>rs10757278</kwd><kwd>rs1333049</kwd><kwd>9Sр21.3 locus</kwd><kwd>family history</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Yusuf S., Hawken S., Ounpuu S. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937–52.</mixed-citation><mixed-citation xml:lang="en">Yusuf S., Hawken S., Ounpuu S. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937–52.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Chow C. K., Islam S., Bautista L. et al. Parental history and myocardial infarction risk across the world: The INTERHEART study. J Am Coll Cardiol 2011; 57: 619–27.</mixed-citation><mixed-citation xml:lang="en">Chow C. K., Islam S., Bautista L. et al. Parental history and myocardial infarction risk across the world: The INTERHEART study. J Am Coll Cardiol 2011; 57: 619–27.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Perk J., Backer G. D., Gohlke H. et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012, doi:10.1093.</mixed-citation><mixed-citation xml:lang="en">Perk J., Backer G. D., Gohlke H. et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012, doi:10.1093.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Cardiovascular prevention. Russian recommendation. Cardiovascular therapy and prevention 2011; 10 (6) (Suppl.2) 64p. Russian (Кардиоваскулярная профилактика. Российские рекомендации ВНОК. Кардиоваскулярная терапия и профилактика. 2011; 10 (6). Приложение 2. 64 с.).</mixed-citation><mixed-citation xml:lang="en">Cardiovascular prevention. Russian recommendation. Cardiovascular therapy and prevention 2011; 10 (6) (Suppl.2) 64p. Russian (Кардиоваскулярная профилактика. Российские рекомендации ВНОК. Кардиоваскулярная терапия и профилактика. 2011; 10 (6). Приложение 2. 64 с.).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Motazacker M. M., Pirruccello J., Huijgen R. et al. Advances in genetics show the need for extending screening strategies for autosomal dominant hypercholesterolaemia. Eur Heart J 2012; 33 (11): 1360–6.</mixed-citation><mixed-citation xml:lang="en">Motazacker M. M., Pirruccello J., Huijgen R. et al. Advances in genetics show the need for extending screening strategies for autosomal dominant hypercholesterolaemia. Eur Heart J 2012; 33 (11): 1360–6.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Van der Net J. B., Oosterveer D. M., Vermissen J. et al. Replication study of 10 genetic polymorphisms associated with coronary heart disease in a specific high-risk population with familial hypercholesterolemia. Eur Heart J 2008; 29: 2195–201.</mixed-citation><mixed-citation xml:lang="en">Van der Net J. B., Oosterveer D. M., Vermissen J. et al. Replication study of 10 genetic polymorphisms associated with coronary heart disease in a specific high-risk population with familial hypercholesterolemia. Eur Heart J 2008; 29: 2195–201.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Maitra A., Dash D., John S. et al. A common variant in chromosome 9p21 associated with coronary artery disease in Asian Indians. J Genet 2010, 88: 113–8.</mixed-citation><mixed-citation xml:lang="en">Maitra A., Dash D., John S. et al. A common variant in chromosome 9p21 associated with coronary artery disease in Asian Indians. J Genet 2010, 88: 113–8.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Hiura Y., Fukushima Y., Yuno M. et al. Validation of the association of genetic variants on chromosome 9p21 and 1q41 with myocardial infarction in a Japanese population. Circ J 2008, 72: 1213–7.</mixed-citation><mixed-citation xml:lang="en">Hiura Y., Fukushima Y., Yuno M. et al. Validation of the association of genetic variants on chromosome 9p21 and 1q41 with myocardial infarction in a Japanese population. Circ J 2008, 72: 1213–7.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Shen G. Q., Rao S., Martinelli N. et al. Association between four SNP’s on chromosome 9p21 and myocardial infarction is replicated in an Italian population. J Hum Gen 2008, 53 (2): 144–150.</mixed-citation><mixed-citation xml:lang="en">Shen G. Q., Rao S., Martinelli N. et al. Association between four SNP’s on chromosome 9p21 and myocardial infarction is replicated in an Italian population. J Hum Gen 2008, 53 (2): 144–150.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Franceschini N., Carty C., Buzkova P. et al. Association of genetic variants and incident coronary heart disease in multiethnic cohorts: the PAGE study. Circ Cardiovasc Genet 2011, 4 (6): 661–72.</mixed-citation><mixed-citation xml:lang="en">Franceschini N., Carty C., Buzkova P. et al. Association of genetic variants and incident coronary heart disease in multiethnic cohorts: the PAGE study. Circ Cardiovasc Genet 2011, 4 (6): 661–72.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Maksimov V. N., Kulikov I. V., Orlov P. S. et al. Evaluation of association between 9 genetic polymorphisms and myocardial infarction in the Siberian population. Annals of the Russian Academy of Medical Sciences 2012, 5: 24–9. Russian (Максимов В. Н., Куликов И. В., Орлов П. С. и др. Проверка взаимосвязи между девятью однонуклеотидными полиморфизмами и инфарктом миокарда на сибирской популяции. Вестник РАМН 2012, 5: 24–9).</mixed-citation><mixed-citation xml:lang="en">Maksimov V. N., Kulikov I. V., Orlov P. S. et al. Evaluation of association between 9 genetic polymorphisms and myocardial infarction in the Siberian population. Annals of the Russian Academy of Medical Sciences 2012, 5: 24–9. Russian (Максимов В. Н., Куликов И. В., Орлов П. С. и др. Проверка взаимосвязи между девятью однонуклеотидными полиморфизмами и инфарктом миокарда на сибирской популяции. Вестник РАМН 2012, 5: 24–9).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Smith J. G., Melander O., Lovkist H. et al. Common genetic variants on chromosome 9p21 confers risk of ischemic stroke: a large-scale genetic association study. Circ Cardiovasc Genet 2009, 2 (2): 159–64.</mixed-citation><mixed-citation xml:lang="en">Smith J. G., Melander O., Lovkist H. et al. Common genetic variants on chromosome 9p21 confers risk of ischemic stroke: a large-scale genetic association study. Circ Cardiovasc Genet 2009, 2 (2): 159–64.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Helgadottir A., Thorleifsson G., Magnusson K. P. et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 2008, 40: 217–24.</mixed-citation><mixed-citation xml:lang="en">Helgadottir A., Thorleifsson G., Magnusson K. P. et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 2008, 40: 217–24.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Bown M. J., Braund P. S., Thompson J. et al. Association between the coronary artery disease risk locus on chromosome 9p21.3 and abdominal aortic aneurysm. Circ Cardiovasc Genet 2008, 1: 39–42.</mixed-citation><mixed-citation xml:lang="en">Bown M. J., Braund P. S., Thompson J. et al. Association between the coronary artery disease risk locus on chromosome 9p21.3 and abdominal aortic aneurysm. Circ Cardiovasc Genet 2008, 1: 39–42.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Nazarenko M. S., Markov A. V., Sleptsov A. A. et al. The status of CDKN2A (P16INK4A и P14ARF) gene methylation in carotid arteries tissue in patient with atherosclerosis. Medical Genetic 2012, 11 (2): 34–7. Russian (Назаренко М. С., Марков А. В., Слепцов А. А. и др. Статус метилирования гена CDKN2A (P16INK4A и P14ARF) в тканях сонных артерий у больных атеросклерозом. Медицинская генетика 2012, 11 (2): 34–7).</mixed-citation><mixed-citation xml:lang="en">Nazarenko M. S., Markov A. V., Sleptsov A. A. et al. The status of CDKN2A (P16INK4A и P14ARF) gene methylation in carotid arteries tissue in patient with atherosclerosis. Medical Genetic 2012, 11 (2): 34–7. Russian (Назаренко М. С., Марков А. В., Слепцов А. А. и др. Статус метилирования гена CDKN2A (P16INK4A и P14ARF) в тканях сонных артерий у больных атеросклерозом. Медицинская генетика 2012, 11 (2): 34–7).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Linsel-Nitschke P., Schunkert H. Chromosome 9p21 and coronary risk – the mystery continues. Atherosclerosis 2011, 214 (2): 257–58.</mixed-citation><mixed-citation xml:lang="en">Linsel-Nitschke P., Schunkert H. Chromosome 9p21 and coronary risk – the mystery continues. Atherosclerosis 2011, 214 (2): 257–58.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Musunuru K., Kathiresan S. Genetics of Coronary Artery Disease. Ann Rev Genomics Hum Genet 2010, 11: 5.1–5.18.</mixed-citation><mixed-citation xml:lang="en">Musunuru K., Kathiresan S. Genetics of Coronary Artery Disease. Ann Rev Genomics Hum Genet 2010, 11: 5.1–5.18.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Broadbent H. M., Peden J. F., Lorkowski S. et al. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet 2008, 17: 806–14.</mixed-citation><mixed-citation xml:lang="en">Broadbent H. M., Peden J. F., Lorkowski S. et al. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet 2008, 17: 806–14.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ye S., Willeit J., Kronenberg F. et al. Association of genetic variation on chromosome 9p21 with susceptibility and progression of atherosclerosis: a population-based, prospective study. J Am Coll Cardiol 2008, 52: 378–84.</mixed-citation><mixed-citation xml:lang="en">Ye S., Willeit J., Kronenberg F. et al. Association of genetic variation on chromosome 9p21 with susceptibility and progression of atherosclerosis: a population-based, prospective study. J Am Coll Cardiol 2008, 52: 378–84.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Schunkert H., Erdmann J., Samani N. J. Genetics of myocardial infarction: a progress report. Eur. Heart J 2010, 31 (8): 918–25.</mixed-citation><mixed-citation xml:lang="en">Schunkert H., Erdmann J., Samani N. J. Genetics of myocardial infarction: a progress report. Eur. Heart J 2010, 31 (8): 918–25.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Buysschaert I., Carruthers K. F., Dunbar D. R. et al. A variant at chromosome 9p21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome: The GRACE Genetics Study. Eur. Heart J 2010, 31: 1132–41.</mixed-citation><mixed-citation xml:lang="en">Buysschaert I., Carruthers K. F., Dunbar D. R. et al. A variant at chromosome 9p21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome: The GRACE Genetics Study. Eur. Heart J 2010, 31: 1132–41.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Scheffold T., Kullmann S., Huge A. et al. Six sequence variants on chromosome 9p21.3 are associated with a positive family history of myocardial infarction: a multicenter registry. BMC Cardiovascular Disorders 2011, 11: 9. doi: 10.1186/1471–2261–11–9.</mixed-citation><mixed-citation xml:lang="en">Scheffold T., Kullmann S., Huge A. et al. Six sequence variants on chromosome 9p21.3 are associated with a positive family history of myocardial infarction: a multicenter registry. BMC Cardiovascular Disorders 2011, 11: 9. doi: 10.1186/1471–2261–11–9.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
